Back
Global Indemnity Group LLC 10K Form
Buy
69
GBLI
Global Indemnity Group LLC
Last Price:
34.38
Seasonality Move:
3.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-10 | 10Q | GBLI/Global Indemnity Group LLC Quarterly |
| 2020-05-08 | 10Q | GBLI/Global Indemnity Group LLC Quarterly |
| 2020-03-06 | 10K | GBLI/Global Indemnity Group LLC Annual |
| 2019-11-08 | 10Q | GBLI/Global Indemnity Group LLC Quarterly |
| 2019-08-09 | 10Q | GBLI/Global Indemnity Group LLC Quarterly |
| 2019-05-10 | 10Q | GBLI/Global Indemnity Group LLC Quarterly |
Receive GBLI News And Ratings
See the #1 stock for the next 7 days that we like better than GBLI
GBLI Financial Statistics
Sales & Book Value
| Annual Sales: | $528.13M |
|---|---|
| Cash Flow: | $15.32M |
| Price / Cash Flow: | 7.96 |
| Annual Sales: | $49.88 |
| Price / Book: | 0.68 |
Profitability
| EPS (TTM): | 2.89000 |
|---|---|
| Net Income (TTM): | $40.12M |
| Gross Margin: | -- |
| Return on Equity: | 6.09% |
| Return on Assets: | 2.3% |
Global Indemnity Group LLC Earnings Forecast
Key Global Indemnity Group LLC Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of GBLI is 4.81% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 11 years.
Global Indemnity Group LLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Insurance |
| Sector: | Financials |
| Current Symbol: | GBLI |
| CUSIP: | G3933F |
| Website: | gbli.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1464.83 |
| Quick Ratio: | 1461.44 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.58 |
|---|---|
| Forward P/E Ratio: | 9.77 |
GBLI Technical Analysis vs Fundamental Analysis
Buy
69
Global Indemnity Group LLC (GBLI)
is a Buy
Is Global Indemnity Group LLC a Buy or a Sell?
-
Global Indemnity Group LLC stock is rated a Buy
The current Global Indemnity Group LLC [GBLI] share price is $34.00. The Score for GBLI is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.